HolderBook

ACASTI PHARMA INC (ACSTXXXX)

Institutional ownership reported to the SEC as of Q2 2023, across 19 quarters.

10
Reporting holders
$169.2K
Reported value
0.0%
Held as options
-1
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
TD PRIVATE CLIENT WEALTH LLC$126.4K240,7970.01%2qHELD
NATIONAL BANK OF CANADA /FI/$9.7K18,4180.00%7qHELD
GEODE CAPITAL MANAGEMENT, LLC$9.6K18,3480.00%8qHELD
TWO SIGMA SECURITIES, LLC$7.9K15,0870.00%newNEW
JANE STREET GROUP, LLC$7.5K14,2160.00%newNEW
MORGAN STANLEY$5.9K11,2950.00%8qHELD
Royal Bank of Canada$2.0K3,5100.00%4qHELD
Federation des caisses Desjardins du Quebec$941790.00%8q-3.2%
RENAISSANCE TECHNOLOGIES LLC$3567,6000.00%2q-25.5%
ICA Group Wealth Management, LLC$29570.00%3qHELD
TD Waterhouse Canada Inc.$340.00%5qHELD

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q2 202310$169.2K321,9112010.0%
Q1 202311$137.7K297,8583100.0%
Q4 20229$15.9K32,1644300.0%
Q3 20229$53.1K93,0733040.0%
Q2 20229$112.2K131,6314010.0%
Q1 202210$204.7K169,1373300.0%
Q4 202111$254.8K201,7871510.0%
Q3 202114$391.5K195,92412020.0%
Q2 202121$1.9M3,351,6267240.0%
Q1 202120$1.3M2,228,3525310.0%
Q4 202025$1.4M4,146,19511520.0%
Q3 202019$258.4K1,246,3264050.0%
Q2 202023$1.3M2,681,7592430.0%
Q1 202024$601.7K1,610,3604760.0%
Q4 201933$12.9M5,250,44215930.0%
Q3 201926$6.7M3,530,00916140.0%
Q2 201913$2.9M2,559,4062530.0%
Q1 201913$2.6M2,506,7334210.0%
Q4 201812$2.3M2,798,9732020.0%